Ingredients
Searchable database of hair loss treatment ingredients with evidence ratings, mechanisms, and interaction warnings.
Searchable database of hair loss treatment ingredients with evidence ratings, mechanisms, and interaction warnings.
Ell-Cranell, 17α-estradiol
Topical estrogen stereoisomer that locally inhibits 5-alpha reductase without systemic hormonal effects.
Olumiant
FDA-approved oral JAK1/JAK2 inhibitor for severe alopecia areata in adults.
Breezula, CB-03-01, Winlevi (acne formulation)
First-in-class topical androgen receptor antagonist; FDA-approved for acne, in trials for AGA.
Leqselvi, CTP-543
Oral JAK1/JAK2 inhibitor FDA-approved in 2024 for severe alopecia areata.
Avodart
Dual 5-alpha reductase inhibitor that reduces DHT by >90%, approved for AGA in Japan and South Korea.
Propecia, Proscar
FDA-approved 5-alpha reductase inhibitor that reduces DHT by ~70%.
Rogaine, Regaine
FDA-approved vasodilator that prolongs anagen phase and increases follicle size.
KX-826
Novel topical androgen receptor inhibitor in phase III trials for AGA in China.
Litfulo
FDA-approved oral JAK3/TEC inhibitor for alopecia areata in patients 12 and older.
Aldactone
Anti-androgen potassium-sparing diuretic used primarily for female pattern hair loss.